Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Aesthetic Surgery Journal|January 29, 2022
Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 3 StudyDaniel S Mueller, Valentina Prinz, Jeffrey Adelglass, et al.
Journal of the American Academy of Dermatology|March 7, 2025
Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studiesDavid Pariser, Dee Anna Glaser, James Del Rosso, et al.
Journal of Drugs in Dermatology : JDD|November 20, 2019
A Cohort Study Using a Facial Cleansing Brush With Acne Cleansing Brush Head and a Gel Cleanser in Subjects With Mild-to-Moderate Acne and Acne-Prone SkinMichael H. Gold, Glynis R. Ablon, Anneke Andriessen, et al.
Clinical, Cosmetic and Investigational Dermatology|March 3, 2026
Concomitant Use of Dermo-Cosmetic Skin Care in Aesthetic Procedures: Systematic Review with Expert Panel RecommendationsAndreas Nikolis, Mark S Nestor, Joanna Czuwara, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 12, 2024
LetibotulinumtoxinA Attenuates the Psychological Burden of Glabellar Lines and Is Associated With High Subject Satisfaction in Phase 3 Clinical TrialsSue Ellen Cox, Joely Kaufman-Janette, Joel L Cohen, et al.
Aesthetic Surgery Journal|September 4, 2012
Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus reviewCorey Maas, Michael A C Kane, Vivian W Bucay, et al.
Journal of Drugs in Dermatology : JDD|February 21, 2006
The use of photodynamic therapy in dermatology: results of a consensus conferenceMark S Nestor, Michael H Gold, Arielle N B Kauvar, et al.
Journal of the American Academy of Dermatology|August 22, 2025
Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III studyTodd Schlesinger, M Shane Chapman, John H Tu, et al.
Pageof 7